Rockwell Medical, Inc. (RMTI)
NASDAQ: RMTI · Real-Time Price · USD
2.200
-0.130 (-5.58%)
At close: Nov 21, 2024, 4:00 PM
2.370
+0.170 (7.73%)
After-hours: Nov 21, 2024, 4:10 PM EST

Rockwell Medical Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Rockwell Medical stock have an average target of 7.00, with a low estimate of 5.00 and a high estimate of 9.00. The average target predicts an increase of 218.18% from the current stock price of 2.20.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $5.00 $7.00 $9.00 $9.00
Change +127.27% +218.18% +309.09% +309.09%

Analyst Ratings

The average analyst rating for RMTI stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Jun '24Jul '24Aug '24Sep '24Oct '24Nov '24
Strong Buy 222222
Buy 000000
Hold 000000
Sell 000000
Strong Sell 000000
Total 222222

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Rodman & Renshaw
Rodman & Renshaw
Strong Buy
Initiates
$5
Strong Buy Initiates $5 +127.27% Nov 14, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$9
Strong Buy Reiterates $9 +309.09% Sep 11, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$9
Strong Buy Reiterates $9 +309.09% Sep 4, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$9
Strong Buy Reiterates $9 +309.09% Aug 12, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$9
Strong Buy Reiterates $9 +309.09% May 16, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
102.17M
from 83.61M
Increased by 22.20%
Revenue Next Year
111.12M
from 102.17M
Increased by 8.76%
EPS This Year
-0.03
from -0.37
EPS Next Year
0.07
from -0.03
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025
Revenue
61.30M62.20M61.93M72.81M83.61M102.17M111.12M
Revenue Growth
-3.29%1.46%-0.43%17.57%14.84%22.20%8.76%
EPS
-6.16-4.49-3.83-1.31-0.37-0.030.07
EPS Growth
-------
Forward PE
------30.81
No. Analysts -----44
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025
High 106.6M 116.2M
Avg 102.2M 111.1M
Low 96.8M 105.1M

Revenue Growth

Revenue Growth 20242025
High
27.5%
13.7%
Avg
22.2%
8.8%
Low
15.8%
2.9%

EPS Forecast

EPS 20242025
High -0.03 0.07
Avg -0.03 0.07
Low -0.03 0.07

EPS Growth

EPS Growth 20242025
High - -
Avg - -
Low - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.